Key facts and Forecast
Financial results for Q1 2025
- Net sales increased organically by 2.5% to € 5.3 billion
- EBITDA pre up organically by 5.8% to € 1.5 billion
- All three business sectors contributed to growth, with the Process Solutions business unit delivering double-digit growth
Guidance 2025
- Company integrates macroeconomic impact into guidance
- Now expects organic sales growth of between 2% and 6% and organic EBITDA pre growth of between 2% and 7%
Overview: business performance in Q1 2025
| Q1 2025 (in € billion) | Change (in %, compared to Q1 2024) | Organic change (in %, compared to Q1 2024) |
|---|---|---|---|
Group net sales |
5.3 |
3.1 |
2.5 |
EBITDA pre |
1.5 |
5.6 |
5.8 |
Life Science sales |
2.2 |
3.5 |
2.5 |
Healthcare sales |
2.1 |
3.2 |
3.4 |
Electronics sales |
0.9 |
2.1 |
0.6 |
"Our solid first-quarter results underscore the resilience of our dynamic, innovation-driven business and our region-for-region approach. We continue to remain confident that we are well-positioned to achieve sustainable growth for 2025 and beyond."
Results & Beyond: Our CFO Speaks
Our CFO Helene von Roeder comments on the Q1 2025 results.
-
![Brochure title]()
Quarterly Statement Q1 2025 (PDF)
Download (PDF)Detailed information about the development of our business in the first quarter of 2025.
ADDITIONAL INFORMATION
Downloads for the Media
- Press Release (PDF)
- Presentation for the Media (PDF)
- Further downloads are available in the Investor Relations Section
Conference calls for the media and analysts
- The conference call for analysts are available as a recording
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Continues to Deliver Growth in Turbulent Times
The company remains confident it will deliver sustainable growth for the year.
2025/05/15
Annual Reports Archive
Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price